Gianfranco Percoco

2.7k total citations · 1 hit paper
26 papers, 2.0k citations indexed

About

Gianfranco Percoco is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gianfranco Percoco has authored 26 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 18 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gianfranco Percoco's work include Coronary Interventions and Diagnostics (17 papers), Acute Myocardial Infarction Research (15 papers) and Antiplatelet Therapy and Cardiovascular Diseases (11 papers). Gianfranco Percoco is often cited by papers focused on Coronary Interventions and Diagnostics (17 papers), Acute Myocardial Infarction Research (15 papers) and Antiplatelet Therapy and Cardiovascular Diseases (11 papers). Gianfranco Percoco collaborates with scholars based in Italy, France and United States. Gianfranco Percoco's co-authors include Marco Valgimigli, Roberto Ferrari, Giovanni Parrinello, Gianluca Campo, Patrizia Malagutti, Fabrizio Ferrari, Gabriele Guardigli, Giordano Cicchitelli, Pascal Vranckx and Dario Barbieri and has published in prestigious journals such as JAMA, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Gianfranco Percoco

26 papers receiving 1.9k citations

Hit Papers

Short- Versus Long-Term Duration of Dual-Antiplatelet The... 2012 2026 2016 2021 2012 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting
    2012 441 citations Marco Valgimigli, Gianluca Campo et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gianfranco Percoco Italy 17 1.7k 1.3k 273 201 143 26 2.0k
Jeehoon Kang South Korea 21 968 0.6× 726 0.6× 237 0.9× 137 0.7× 138 1.0× 125 1.5k
Argyrios Ntalianis Greece 22 931 0.6× 846 0.7× 631 2.3× 68 0.3× 194 1.4× 49 1.5k
Shuichi Oshima Japan 18 682 0.4× 437 0.3× 268 1.0× 63 0.3× 187 1.3× 59 1.2k
Luigi Oltrona Italy 15 1.1k 0.6× 354 0.3× 266 1.0× 277 1.4× 174 1.2× 32 1.4k
J H Chesebro United States 11 812 0.5× 562 0.4× 222 0.8× 237 1.2× 237 1.7× 19 1.2k
Aleksander Araszkiewicz Poland 18 840 0.5× 642 0.5× 240 0.9× 175 0.9× 474 3.3× 132 1.3k
Petra Hoppmann Germany 22 911 0.6× 574 0.4× 147 0.5× 133 0.7× 223 1.6× 66 1.4k
Bart J.G.L. de Smet Netherlands 18 1.3k 0.8× 1.1k 0.9× 656 2.4× 215 1.1× 251 1.8× 39 1.9k
Jesse W. Currier United States 16 764 0.5× 938 0.7× 386 1.4× 38 0.2× 276 1.9× 55 1.4k
Jlenia Marchesini Italy 15 932 0.6× 711 0.6× 72 0.3× 155 0.8× 102 0.7× 23 1.3k

Countries citing papers authored by Gianfranco Percoco

Since Specialization
Citations

This map shows the geographic impact of Gianfranco Percoco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gianfranco Percoco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gianfranco Percoco more than expected).

Fields of papers citing papers by Gianfranco Percoco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gianfranco Percoco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gianfranco Percoco. The network helps show where Gianfranco Percoco may publish in the future.

Co-authorship network of co-authors of Gianfranco Percoco

This figure shows the co-authorship network connecting the top 25 collaborators of Gianfranco Percoco. A scholar is included among the top collaborators of Gianfranco Percoco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gianfranco Percoco. Gianfranco Percoco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Valgimigli, Marco, Gianluca Campo, Monia Monti, et al.. (2012). Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting. Circulation. 125(16). 2015–2026. 441 indexed citations breakdown →
2.
Pratola, Claudio, Lina Marcantoni, Tiziano Toselli, et al.. (2011). Different Image Integration Modalities to Guide AF Ablation: Impact on Procedural and Fluoroscopy Times. Pacing and Clinical Electrophysiology. 34(4). 422–430. 24 indexed citations
3.
Valgimigli, Marco, Gianluca Campo, Gianfranco Percoco, et al.. (2010). Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention. American Heart Journal. 160(5). 804–811. 50 indexed citations
4.
Valgimigli, Marco, Gianluca Campo, Nicoletta De Cesare, et al.. (2009). Intensifying Platelet Inhibition With Tirofiban in Poor Responders to Aspirin, Clopidogrel, or Both Agents Undergoing Elective Coronary Intervention. Circulation. 119(25). 3215–3222. 172 indexed citations
5.
Valgimigli, Marco, Gianluca Campo, Nicoletta De Cesare, et al.. (2008). Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel (3T/2R). Rationale for the Study and Protocol Design. Cardiovascular Drugs and Therapy. 22(4). 313–320. 16 indexed citations
6.
Vignali, Luigi, Francesco Saia, Antonio Manari, et al.. (2008). Long-Term Outcomes With Drug-Eluting Stents Versus Bare Metal Stents in the Treatment of Saphenous Vein Graft Disease (Results from the REgistro Regionale AngiopLastiche Emilia-Romagna Registry). The American Journal of Cardiology. 101(7). 947–952. 34 indexed citations
7.
Campo, Gianluca, Francesco Saia, Gianfranco Percoco, et al.. (2008). Long-term outcome after drug eluting stenting in patients with ST-segment Elevation Myocardial Infarction. International Journal of Cardiology. 140(2). 154–160. 17 indexed citations
8.
Luca, Giuseppe De, Gregg W. Stone, Harry Suryapranata, et al.. (2008). Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: A meta-analysis of randomized trials. International Journal of Cardiology. 133(2). 213–222. 78 indexed citations
9.
Campo, Gianluca, Marco Valgimigli, Donato Gemmati, et al.. (2007). Poor Responsiveness to Clopidogrel: Drug-Specific or Class-Effect Mechanism?. Journal of the American College of Cardiology. 50(12). 1132–1137. 57 indexed citations
10.
Valgimigli, Marco, Gianluca Campo, Patrizia Malagutti, et al.. (2007). Two-Year Clinical Follow-Up After Sirolimus-Eluting Versus Bare-Metal Stent Implantation Assisted by Systematic Glycoprotein IIb/IIIa Inhibitor Infusion in Patients With Myocardial Infarction. Journal of the American College of Cardiology. 50(2). 138–145. 65 indexed citations
11.
Valgimigli, Marco, Nicole Mittmann, David J. Cohen, et al.. (2007). A strategy to offset the extra cost of sirolimus-eluting stent in patients undergoing intervention for acute myocardial infarction. International Journal of Cardiology. 128(1). 53–61. 1 indexed citations
12.
Campo, Gianluca, Marco Valgimigli, Donato Gemmati, et al.. (2006). Value of Platelet Reactivity in Predicting Response to Treatment and Clinical Outcome in Patients Undergoing Primary Coronary Intervention. Journal of the American College of Cardiology. 48(11). 2178–2185. 122 indexed citations
13.
Percoco, Gianfranco, Antonio Manari, Paolo Guastaroba, et al.. (2006). Safety and Long-Term Efficacy of Sirolimus Eluting Stent in ST-elevation Acute Myocardial Infarction: The REAL (Registro REgionale AngiopLastiche Emilia-Romagna) Registry. Cardiovascular Drugs and Therapy. 20(1). 63–68. 16 indexed citations
14.
Campo, Gianluca, Marco Valgimigli, P. Ferraresi, et al.. (2006). Tissue Factor and Coagulation Factor VII Levels During Acute Myocardial Infarction. Arteriosclerosis Thrombosis and Vascular Biology. 26(12). 2800–2806. 44 indexed citations
15.
Valgimigli, Marco, Gianfranco Percoco, Patrizia Malagutti, et al.. (2005). Tirofiban and Sirolimus-Eluting Stent vs Abciximab and Bare-Metal Stent for Acute Myocardial Infarction. JAMA. 293(17). 2109–2109. 225 indexed citations
16.
Valgimigli, Marco, Gianluca Campo, Gianfranco Percoco, et al.. (2005). Tirofiban: A Critical Reappraisal of the Clinical use, Recent Developments and Future Perspectives. Future Cardiology. 2(1). 17–27. 2 indexed citations
17.
Valgimigli, Marco, Gian Matteo Rigolin, Corrado Cittanti, et al.. (2005). Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile. European Heart Journal. 26(18). 1838–1845. 162 indexed citations
18.
Valgimigli, Marco, Gianfranco Percoco, Giordano Cicchitelli, et al.. (2004). High-Dose BoluS TiRofibAn and Sirolimus Eluting STEnt versus Abiciximab and Bare Metal Stent in Acute MYocardial Infarction (STRATEGY) Study—Protocol Design and Demography of the First 100 Patients. Cardiovascular Drugs and Therapy. 18(3). 225–230. 13 indexed citations
19.
Valgimigli, Marco, Gianfranco Percoco, Dario Barbieri, et al.. (2004). The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty. Journal of the American College of Cardiology. 44(1). 14–19. 100 indexed citations
20.
Ansani, L, et al.. (1993). Intracardiac thyroid heterotopia. American Heart Journal. 125(6). 1797–1801. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeehoon Kang Breakdown of academic impact, for papers by Argyrios Ntalianis Breakdown of academic impact, for papers by Shuichi Oshima Breakdown of academic impact, for papers by Luigi Oltrona Breakdown of academic impact, for papers by J H Chesebro Breakdown of academic impact, for papers by Aleksander Araszkiewicz Breakdown of academic impact, for papers by Petra Hoppmann Breakdown of academic impact, for papers by Bart J.G.L. de Smet Breakdown of academic impact, for papers by Jesse W. Currier Breakdown of academic impact, for papers by Jlenia Marchesini
Rankless by CCL
2026